Salt Lake City, UT, United States of America

Alexander Gutin

This inventor holds 33 USPTO granted patents and 50 published patent applications, plus 6 CIPO patents and 19 EPO patents, primarily in Cancer Biomarkers. Top assignees: Myriad Genetics, Inc., Myriad Mypath, LLC, The University of Texas System. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Gutin. Retrieved from https://idiyas.com/inventor/alexander-gutin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 50)

% Patents Active = 87.9

CIPO Patents = 6 (Patent Applications = 17)

EPO Patents = 19 (Patent Applications = 51)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 50(Granted Patents)

Location History:

Sandy, UT (US) (2010)
Salt Lake City, UT (US) (2010 - 2023)

Company Filing History:

28 out of 122

Myriad Genetics, Inc.

The University of Texas System

patents

4. 1 out of 127

Laboratory Corporation of America Holdings

patents

5. 1 out of 4

Myriad International Gmbh

patents

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Cancer Biomarkers

Gene Signatures

Heterozygosity

Homologous Recombination

Melanoma

Chemotherapy Benefit

Disease Activity Score

Allelic Imbalance

Prognosis

Genetic Profiling

Cancer Risk

Inflammatory Disease

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12680139 - Cancer biomarkers (2026-07-14),

2. 12674207 - Methods and materials for assessing loss of heterozygosity (2026-07-07),

3. 12637716 - Detecting cancer risk (2026-05-26),

4. 12595513 - Methods and materials for assessing loss of heterozygosity (2026-04-07),

5. 12577622 - Detecting cancer risk (2026-03-17),

6. 12421555 - Methods and materials for assessing homologous recombination deficiency (2025-09-23),

7. 12392785 - Adjusted multi-biomarker disease activity score for inflammatory disease assessment (2025-08-19),

8. 12371750 - Genes and gene signatures for diagnosis and treatment of melanoma (2025-07-29),

9. 12221656 - Methods and materials for assessing homologous recombination deficiency (2025-02-11),

10. 12180551 - Method of using biomarkers and clinical variables for predicting chemotherapy benefit (2024-12-31),

11. 11834719 - Genes and gene signatures for diagnosis and treatement of melanoma (2023-12-05),

12. 11584967 - Genes and gene signatures for diagnosis and treatment of melanoma (2023-02-21),

13. 11505832 - Method of using biomarkers and clinical variables for predicting chemotherapy benefit (2022-11-22),

14. 11225685 - Methods and materials for assessing allelic imbalance (2022-01-18),

15. 11174519 - Method of treating cancer (2021-11-16),

Title: The Innovative Mind of Alexander Gutin

Introduction: Alexander Gutin, a brilliant inventor based in Salt Lake City, UT, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Alexander Gutin holds several patents in the areas of renewable energy technologies, artificial intelligence systems, and advanced medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Alexander Gutin has worked with leading tech companies and research institutions, spearheading projects that have revolutionized various industries. His commitment to pushing the boundaries of innovation has earned him recognition as a visionary in the field.

Collaborations: Throughout his career, Alexander Gutin has collaborated with top engineers, scientists, and designers to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful development of cutting-edge products and solutions.

Conclusion: Alexander Gutin's passion for innovation, coupled with his relentless drive to solve complex challenges, continues to inspire the next generation of inventors. His impact on the world of technology is truly remarkable, and his legacy will undoubtedly endure for years to come.

Profile summary based on public USPTO records.